Director/PDMR Shareholding

RNS Number:4061A
Bespak PLC
27 March 2006


For immediate release                                              27 March 2006



                                    Bespak plc

                                ('the Company')

                            Directors' Share Purchase

Bespak plc (LSE: BPK), a leader in specialty medical devices, reports that Mark
Throdahl, Chief Executive, and Martin Hopcroft, Group Finance Director, both
purchased shares and increased their shareholding in the Company on Thursday 23
March 2006.

Mark Throdahl purchased 25,500 ordinary shares of 10p each in the Company at
575p each, increasing his stake in the Company's issued share capital to 0.358%.

Martin Hopcroft purchased 2,000 ordinary shares of 10p each in the Company at
559.6p each, increasing his stake in the Company's issued share capital to 
0.027%.

                                      ENDS

For further information please call:

Bespak plc
Mark Throdahl - Chief Executive                        [phone]
Martin Hopcroft - Group Finance Director

Buchanan Communications                                [phone]
Tim Thompson / Mark Court / Mary-Jane Johnson



Notes for Editors:


About Bespak plc
Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings. Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes. The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on the
Official List of the London Stock Exchange (LSE: BPK). For more information,
please visit www.bespak.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSBIGDXLUDGGLS